Kwality Pharmaceuticals received ANVISA approval for Cephalosporin Plant, Unit -II

Kwality Pharmaceuticals Ltd's finished dosage form manufacturing facility, after the approval of Oncology Injectable Unit from Anvisa, the Cephalosporin Unit situated at Himachal Pradesh has also been approved by ANVISA, Brazilian Health Regulatory Authority.

The lines approved are- powder for injection, tablet, capsule and dry syrup. After approval from Brazil's National Health Surveillance Agency ANVISA, Kwality Pharma has access to Brazilian Pharmaceutical Market for above mentioned lines also.

Now all existing units of Kwality pharmaceuticals are Pic' approved. This allows Kwality Pharma to register and participate in tenders in 56 Pic's member countries.

Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 315.40 as compared to the previous close of Rs. 316.60. The total number of shares traded during the day was 4533 in over 117 trades.

The stock hit an intraday high of Rs. 323.90 and intraday low of 310.30. The net turnover during the day was Rs. 1435734.00.

Source : Equity Bulls

Keywords

KwalityPharmaceuticals INE552U01010 ANVISA Approval CephalosporinUnit HimachalPradesh